Link JM - Search Results

1

Carbon-11-thymidine and FDG to measure therapy response.

Shields AF, Mankoff DA, Link JM, Graham MM, Eary JF, Kozawa SM, Zheng M, Lewellen B, Lewellen TK, Grierson JR, Krohn KA. Shields AF, et al. Among authors: link jm. J Nucl Med. 1998 Oct;39(10):1757-62. J Nucl Med. 1998. PMID: 9776283 Free article.

2

The FDG lumped constant in normal human brain.

Graham MM, Muzi M, Spence AM, O'Sullivan F, Lewellen TK, Link JM, Krohn KA. Graham MM, et al. Among authors: link jm. J Nucl Med. 2002 Sep;43(9):1157-66. J Nucl Med. 2002. PMID: 12215553 Free article.

3

18F-FDG PET of gliomas at delayed intervals: improved distinction between tumor and normal gray matter.

Spence AM, Muzi M, Mankoff DA, O'Sullivan SF, Link JM, Lewellen TK, Lewellen B, Pham P, Minoshima S, Swanson K, Krohn KA. Spence AM, et al. Among authors: link jm. J Nucl Med. 2004 Oct;45(10):1653-9. J Nucl Med. 2004. PMID: 15471829 Free article. Clinical Trial.

4

True tracers: comparing FDG with glucose and FLT with thymidine.

Krohn KA, Mankoff DA, Muzi M, Link JM, Spence AM. Krohn KA, et al. Among authors: link jm. Nucl Med Biol. 2005 Oct;32(7):663-71. doi: 10.1016/j.nucmedbio.2005.04.004. Nucl Med Biol. 2005. PMID: 16243640 Review.

5

C11-acetate and F-18 FDG PET for men with prostate cancer bone metastases: relative findings and response to therapy.

Yu EY, Muzi M, Hackenbracht JA, Rezvani BB, Link JM, Montgomery RB, Higano CS, Eary JF, Mankoff DA. Yu EY, et al. Among authors: link jm. Clin Nucl Med. 2011 Mar;36(3):192-8. doi: 10.1097/RLU.0b013e318208f140. Clin Nucl Med. 2011. PMID: 21285676 Free PMC article. Clinical Trial.

6

Multiagent PET for risk characterization in sarcoma.

Eary JF, Link JM, Muzi M, Conrad EU, Mankoff DA, White JK, Krohn KA. Eary JF, et al. Among authors: link jm. J Nucl Med. 2011 Apr;52(4):541-6. doi: 10.2967/jnumed.110.083717. Epub 2011 Mar 18. J Nucl Med. 2011. PMID: 21421714 Free PMC article.

7

Between-patient and within-patient (site-to-site) variability in estrogen receptor binding, measured in vivo by 18F-fluoroestradiol PET.

Kurland BF, Peterson LM, Lee JH, Linden HM, Schubert EK, Dunnwald LK, Link JM, Krohn KA, Mankoff DA. Kurland BF, et al. Among authors: link jm. J Nucl Med. 2011 Oct;52(10):1541-9. doi: 10.2967/jnumed.111.091439. Epub 2011 Sep 8. J Nucl Med. 2011. PMID: 21903739 Free PMC article.

8

Utilization of labeled thymidine in DNA synthesis: studies for PET.

Shields AF, Lim K, Grierson J, Link J, Krohn KA. Shields AF, et al. J Nucl Med. 1990 Mar;31(3):337-42. J Nucl Med. 1990. PMID: 2308005 Free article.

9

Contribution of labeled carbon dioxide to PET imaging of carbon-11-labeled compounds.

Shields AF, Graham MM, Kozawa SM, Kozell LB, Link JM, Swenson ER, Spence AM, Bassingthwaighte JB, Krohn KA. Shields AF, et al. Among authors: link jm. J Nucl Med. 1992 Apr;33(4):581-4. J Nucl Med. 1992. PMID: 1552344 Free article.

10

Analysis of 2-carbon-11-thymidine blood metabolites in PET imaging.

Shields AF, Mankoff D, Graham MM, Zheng M, Kozawa SM, Link JM, Krohn KA. Shields AF, et al. Among authors: link jm. J Nucl Med. 1996 Feb;37(2):290-6. J Nucl Med. 1996. PMID: 8667064 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

163 results

Search Page

Filters